Introduction
We are advancing the future of immunization.
● Over 40 Years of Vaccine Innovation,
● With 3 Globally Approved Vaccines,
● 11 Invention Patents,
● 2 Prestigious European Research-to-Market Awards,
● and over €500 Million in Research Funding Secured—
Full-cycle new drug development services — from early-stage research to commercialization.
International cooperation: our service network covers Europe and Asia.